Update on intestinal microbiota in Crohn's disease 2017: Mechanisms, clinical application, adverse reactions, and outlook
Author:
Affiliation:
1. Department of Gastroenterology, Third Xiangya Hospital; Central South University; Changsha Hunan China
2. Hunan Key Laboratory of Non-Resolving Inflammation and Cancer; Changsha Hunan China
Funder
The New Xiangya Talent Project of the Third Xiangya Hosipital of Central South University
National Natural Science Foundation of China
Publisher
Wiley
Subject
Gastroenterology,Hepatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/jgh.13861/fullpdf
Reference74 articles.
1. Intestinal microbiota in inflammatory bowel disease: friend of foe?;Fava;World J. Gastroenterol.,2011
2. Inflammatory bowel disease: established and evolving considerations on its etiopathogenesis and therapy;Schirbel;J. Dig. Dis.,2010
3. Fecal microbiota transplantation: effectiveness, complexities, and lingering concerns;Pamer;Mucosal Immunol.,2014
4. Dysbiosis of gut fungal microbiota is associated with mucosal inflammation in Crohn's disease;Li;J. Clin. Gastroenterol.,2014
5. Letter: faecal microbiota transplantation-not a one-size-fits-all approach;Ianiro;Aliment. Pharmacol. Ther.,2014
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Fecal microbiota transplantation alleviates mild‐moderate COVID‐19 associated diarrhoea and depression symptoms: A prospective study of a randomized, double‐blind clinical trial;Journal of Medical Virology;2024-07-26
2. The gut microbes in inflammatory bowel disease: Future novel target option for pharmacotherapy;Biomedicine & Pharmacotherapy;2023-09
3. Nanoprobiotics for Remolding the Pro-inflammatory Microenvironment and Microbiome in the Treatment of Colitis;Nano Letters;2023-08-25
4. PF-431396 hydrate inhibition of kinase phosphorylation during adherent-invasive Escherichia coli infection inhibits intra-macrophage replication and inflammatory cytokine release;Microbiology;2023-06-13
5. Hybrid Bacteria System with Nanomaterials for Tumor Therapy;Advanced NanoBiomed Research;2023-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3